The Horseracing Integrity and Safety Authority (HISA) is launching a comprehensive study to examine the effects of furosemide, known as Lasix, on racehorses. With $773,500 in grant funding, the research will involve top institutions and aims to determine whether the drug enhances performance when administered 48 hours before a race. The outcomes will guide future regulatory decisions to ensure the welfare of Thoroughbreds.